Arcadia Biosciences, Inc.
RKDA
$2.88
-$0.0767-2.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.45% | 37.20% | 28.92% | 74.18% | 32.78% |
| Total Depreciation and Amortization | -22.97% | -41.20% | -14.34% | -9.16% | -21.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 804.25% | 71.57% | 11.65% | -107.21% | -193.01% |
| Change in Net Operating Assets | 61.01% | 37.27% | 92.35% | -420.00% | -194.75% |
| Cash from Operations | 46.71% | 39.27% | 48.81% | 7.39% | -75.93% |
| Capital Expenditure | -- | -- | 40.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -110.96% | 3,500.00% | 1,971.43% | -43.33% | 217.39% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12,114.29% | -- | 195.40% | -- | -107.39% |
| Cash from Investing | 4,736.54% | 3,500.00% | 198.45% | -98.73% | -81.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -42.86% | -- | -99.92% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -42.86% | -- | -99.91% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.48% | 45.42% | 122.99% | -235.98% | -97.25% |